Lymphedema of the lower extremities is a chronic condition characterized by the accumulation of lymphatic fluid, leading to swelling, discomfort, and potential complications. Intermittent pneumatic compression (IPC) has emerged as a noninvasive treatment option aimed at reducing edema and improving lymphatic function. Lymphedema of the lower extremities is a chronic condition that significantly impacts quality of life and functional mobility. This study investigates the long-term effectiveness of Intermittent Pneumatic Compression (IPC) therapy as a treatment modality for managing lower extremity lymphedema.Intermittent Pneumatic Compression (IPC) has emerged as a promising treatment for managing lower extremity lymphedema. This paper evaluates the long-term effectiveness of IPC therapy and its impact on both physical and psychological outcomes for patients with chronic lower extremity lymphedema. Through a review of existing studies, including those by Dunn et al. (2022), Zaleska et al. (2014), and Desai et al. (2020), the authors explore the potential benefits and challenges of IPC therapy. Findings indicate that IPC can significantly improve limb volume reduction, enhance functional mobility, and boost the overall quality of life in patients. However, the review also underscores the need for further clinical trials and research to standardize IPC protocols and treatment regimens. The study concludes that while IPC presents a viable long-term therapeutic option, more data is necessary to refine its efficacy and ensure optimal patient outcomes.